An international standard for biometric injection attack detection is now in development by the International Standard for ...

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...

This article examines viral and non-viral vectors in gene therapy, highlighting their mechanisms, advantages, and limitations ...

For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that ...

"It's been a tremendous success and has proven to be a lifesaving treatment," said José Luis Millán, PhD, professor in the Human Genetics ... the site of injection of the viral vector.

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that must be delivered by injection three-to-six times each week.

For the last 10 years, the only effective treatment for hypophosphatasia (HPP) has been an enzyme replacement therapy that must be delivered by ...

Published first as a whitepaper in late 2024, the 2025 OWASP Top 10 for LLM Applications is yet another monumental effort from OWASP made possible by a large number of experts in the fields of AI, ...

Civil unrest in key endemic regions, such as the Central African Republic and southwestern Cameroon, has hindered disease ...

Researchers have developed a gene therapy that may provide a long-term treatment for hypophosphatasia. Unlike current ...